Leadership Team

 

angel2

 

 

 

 

Dr. Itzchak Angel, Founder and Chief Executive Officer

The company has been founded by Dr. Itzchak Angel, CEO, an accomplished executive in the pharmaceutical industry, with over 30 years experience in guiding strategic drug- and business-development in both large and emerging companies, and brought several drugs to market. Dr. Angel was previously Head of Pharmacology at Sanofi (Formerly Synthelabo, Paris, France) and brought several drugs to market (Ambien, Xatral, Migpriv and Mizollen). He has formerly been VP R&D at Proteologics Ltd and at D-Pharm Biopharmaceuticals (Rehovot, Israel) where he developed several compounds into advanced clinical development.  Dr. Angel has a confirmed experience and network in business development and pharmaceutical deals. He is co-inventor and co-author of over 100 patents and publications.

 

Scientific Advisory Board

 

aaroncik

 

 

 

 

 

Prof. Aaron Ciechanover

Prof. Aaron Ciechanover, Nobel laureate for Chemistry (2004) form the Technion, has joined the Scientific Advisory Board of Novitero. Prof. Ciechanover is a distinguished professor at the Tumor and Vascular Biology Research Center at The Rappaport Faculty of Medicine and Research Institute – Technion-Israel Institute of Technology. Prior to receiving the Nobel Prize he was a recipient of the 2000 Albert Lasker Award and the 2003 Israel Prize. He is the recipient of the 2011 Humboldt Research Award of the Alexander von Humboldt Foundation. He is a member of the Israeli Academy of Sciences and Humanities, and the National Academy of Sciences of the USA.

 

warshel

 

 

 

 

 

Prof. Arieh Warshel

Prof. Arieh Warshel, Nobel Laureate for Chemistry 2013, has joined the Scientific Advisory Board of Novitero. He is a Distinguished Professor of Chemistry and Biochemistry, Dana and David Dornsife Chair in Chemistry, Member of the Norris cancer center, University of Southern California. Prior to receiving the Nobel Prize, he was a recipient of the 1993 Award of the International Society of Quantum Biology and Pharmacology, the Tolman Medal 2003, President’s award for computational biology from the ISQBP (2006 )and the RSC Soft Matter and Biophysical Chemistry Award (2012). He is a member of the National Academy of Sciences.

Comments are closed.